Milestone Scientific's STA Single Tooth Anesthesia System® Named as One of Dentistry Today's 'Top 100 Products' for Third Consecutive Year
LIVINGSTON, N.J., July 27 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that the Company's patented, award-winning STA Single Tooth Anesthesia System® has again been distinguished as one of the "Top 100 Products" of the year by Dentistry Today, the nation's leading clinical news magazine for dentists.
For the past 24 years, Dentistry Today has recognized the industry's leading dental products through its "Top 100 Products" awards program. The "2010 Top 100 Products" marks the third consecutive year that the STA Single Tooth Anesthesia System has been honored as a winning technology. As such, the STA Single Tooth Anesthesia System has been featured in the special Top 100 section of the publication's July issue.
Leonard Osser, Chief Executive Officer of Milestone, stated, "We're very proud to have our STA Single Tooth Anesthesia System again recognized as one of the dental market's leading technologies by one of the industry's most respected publications. The sheer volume of awards that the STA Single Tooth Anesthesia System has won over the past three years is unprecedented in our Company's 15-year history and has served to support our objective of establishing the instrument as the new global standard of care for painless dental injections."
The STA Single Tooth Anesthesia System takes the guesswork out of the administration of anesthetic by providing real-time visual and audible feedback via Milestone's portfolio of patented technologies for subcutaneous drug delivery for medical and dental applications. The instrument utilizes Milestone's patented CompuFlo® technology with DPS Dynamic Pressure Sensing® for the painless delivery and aspiration of all medicaments. During an injection using the STA Single Tooth Anesthesia System, continuous monitoring of the exit pressure of the anesthetic enables a predictable and painless "Single Tooth Anesthesia" to be performed, something that was never before possible using conventional techniques. The benefits of administering injections with the instrument are significant for the patient, the dentist and the business of Dentistry.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled injection technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North America, Asia, Africa and Europe. For more information on the STA Single Tooth Anesthesia System® and other innovative Milestone products, please visit the Company's web sites found at www.milestonescientific.com and www.STAis4U.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2009. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group Dodi Handy, President and CEO (Twitter: @dodihandy) For Media Inquiries: Kathy Addison, Director, Elite Media Group (Twitter:@kathyaddison) 407-585-1080 or via email email@example.com
SOURCE Milestone Scientific Inc.
Released July 27, 2010